Impact of the Nationwide Avastin Ban at a Tertiary Eye Care Hospital in Pakistan
Impact of the Nationwide Avastin Ban at a Tertiary Eye Care Hospital in Pakistan
About this item
Full title
Author / Creator
Publisher
United States: Cureus Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Cureus Inc
Subjects
More information
Scope and Contents
Contents
To report the impact of a 10-week-long nationwide ban on intra-vitreal bevacizumab (IVB) injection (Avastin®) at a tertiary care hospital in Pakistan.
This was a single-center, retrospective, cohort study. Patients scheduled for IVB injections from October 25, 2023 to October 29, 2023 who arrived in OPD between November 28, 2023 and December 15...
Alternative Titles
Full title
Impact of the Nationwide Avastin Ban at a Tertiary Eye Care Hospital in Pakistan
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11341108
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11341108
Other Identifiers
ISSN
2168-8184
E-ISSN
2168-8184
DOI
10.7759/cureus.65199
